Moderna shares are trading higher after the company reportedly entered a cancer collaboration with CARsgen. Additionally, the company last week announced COVID vaccine effectiveness against the EG.5 and FL.1.5.1 variants.
Portfolio Pulse from Benzinga Newsdesk
Moderna has entered a cancer collaboration with CARsgen and announced the effectiveness of its COVID vaccine against the EG.5 and FL.1.5.1 variants. This news has led to a rise in Moderna's share prices.
August 21, 2023 | 2:45 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Moderna's stock is trading higher due to a new cancer collaboration with CARsgen and the effectiveness of its COVID vaccine against new variants.
The announcement of a new partnership with CARsgen for cancer research and the effectiveness of Moderna's COVID vaccine against new variants has positively impacted investor sentiment, leading to a rise in Moderna's stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100